LEMAITRE VASCULAR INC (LMAT) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 1115 transactions totaling $194.4M, demonstrating a bearish sentiment with -$194.0M in net insider flow. The most recent transaction on Dec 12, 2025 involved a transaction of 5 shares valued at $0.
No significant insider buying has been recorded for LMAT in the recent period.
No significant insider selling has been recorded for LMAT in the recent period.
Based on recent SEC filings, insider sentiment for LMAT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$194.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at LEMAITRE VASCULAR INC (LMAT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading LMAT stock, having executed 1115 transactions in the past 90 days. The most active insider is George W. Lemaitre (Executive), who has made 348 transactions totaling $149.7M.
Get notified when executives and directors at LMAT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | A. Roush John | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | A. Roush John | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | J. Jasinski Lawrence | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | J. Jasinski Lawrence | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | James O'connor John | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | James O'connor John | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | A. Ross Bridget | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | A. Ross Bridget | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | Shadan Martha | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | Shadan Martha | Executive | Option Exercise | 5 | $N/A | $0 | |
| Dec 12, 2025 | P. Pellegrino Joseph Jr | Executive | Option Exercise | 18 | $N/A | $0 | |
| Dec 12, 2025 | P. Pellegrino Joseph Jr | Executive | Option Exercise | 18 | $N/A | $0 | |
| Dec 12, 2025 | G. Kamke Trent | Executive | Option Exercise | 8 | $N/A | $0 | |
| Dec 12, 2025 | G. Kamke Trent | Executive | Payment | 90 | $84.00 | $7.6K | |
| Dec 12, 2025 | G. Kamke Trent | Executive | Payment | 90 | $84.00 | $7.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 409 | $194.2M | 84.1% |
Exercise(M) | 450 | $33.5M | 14.5% |
Payment(F) | 154 | $2.0M | 0.9% |
Award(A) | 74 | $1.0M | 0.4% |
Purchase(P) | 3 | $205.3K | 0.1% |
Gift(G) | 25 | $0 | 0.0% |
Insider selling pressure at LEMAITRE VASCULAR INC has increased, with 14 insiders executing 1115 transactions across all time. Total sales of $194.2M significantly outpace purchases of $205.3K, resulting in a net outflow of $194.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.